New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 3, 2000, Pages 163-184

  Kato, Shinsuke ^a   Takikawa, Miki ^a   Nakashima, Kenji ^a   Hirano, Asao ^b   Cleveland, Don W ^c   Kusaka, Hirofumi ^d   Shibata, Noriyuki ^e   Kato, Masako ^a   Nakano, Imaharu ^f   Ohama, Eisaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Familial Amyotrophic Lateral Sclerosis (FLAS) Neuronal Lewy BODY LIKE Hyaline Inclusions (LBHIS) Astrocytic Hyaline Inclusions (AST HIS) Superoxide Dismutase 1 (SOD1) Granule COATED Fibris

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL INCLUSION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; HUMANS; INCLUSION BODIES; MUTATION; NEURONS; SUPEROXIDE DISMUTASE;

EID: 0034209203     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820050515160     Document Type: Review

References (130)

1. Hirano A. Neuropathology of ALS: An overview. Neurology 1996; 47(Suppl 2): S63-S66. (Pubitemid 26361997)
2. de Belleroche J, Orrell RW, Virgo L. Amyotrophic lateral sclerosis: Recent advances in understanding disease mechanisms. J Neuropathol Exp Neurol 1996; 55: 747-757. (Pubitemid 26238578)
3. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: A review. Brain 1981; 104: 217-247. (Pubitemid 12183320)
4. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: Progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 1997; 48: 55-57. (Pubitemid 27039517)
5. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 1986; 36: 511-517. (Pubitemid 16070005)
6. Engel WK, Kurland LT, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement: An intermediate form? Brain 1959; 82: 203-220.
7. Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antérolaté raux de la moelle épinière. Arch Physiol (Paris) 1869; 2: 744-760.
8. Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991; 324: 1381-1384.
9. Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismu-tase. Science 1993; 261: 1047-1051. (Pubitemid 23300865)
10. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62. (Pubitemid 23087289)
11. Levanon D, Lieman-Hurwitz J, Dafni N, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J 1985; 4: 77-84.
12. Weisiger RA, Fridovich I. Mitochondrial superoxide dismu-tase: Site of synthesis and intramitochondrial localization. J Biol Chem 1973; 248: 4793-4796.
13. Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 1986; 58: 61-97.
14. Weitkamp L, Francke U. Report of the committee on the genetic constitution of chromosome 6. Cytogenet Cell Genet 1978; 22: 92-105. (Pubitemid 9168848)
15. Hendrickson DJ, Fisher JH, Jones C, Ho YS. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics 1990; 8: 736-738.
16. Rothstein JD, Kammen MV, Levy AI, Martin LI, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
17. Richardson JS, Richardson DC, Thomas KA. Similarity of three-dimensional structure between immunoglobulin domain and the copper,zinc superoxide dismutase subunit. J Mol Biol 1976; 102: 221-235.
18. Getzoff ED, Tainer JA, Stempien MM, Bell GI, Hallewell RA. Evolution of CuZn superoxide dismutase and the Greek key beta-barrel structural motif. Proteins 1989; 5: 322-336. (Pubitemid 19189328)
19. Siddique T, Nijhawan D, Hentati A. Familial amyotrophic lateral sclerosis. J Neural Transm 1997; 49(Suppl): 219-233. (Pubitemid 27351490)
20. Tainer JA, Getzoff ED, Beem KM, Richardson JS, Richardson DC. Determination and analysis of the 2 Å structure of copper, zinc superoxide dismutase. J Mol Biol 1982; 160: 181-217. (Pubitemid 13239300)
21. Bordo D, Djinovic K, Bolognesi M. Conserved patterns in the Cu, Zn superoxide dismutase family. J Mol Biol 1994; 238: 366-386. (Pubitemid 24154718)
22. Boissinot M, Karnas S, Lepock JR, et al. Function of the Greek key connection analysed using circular permutants of superoxide dismutase. EMBO J 1997; 16: 2171-2178. (Pubitemid 27258620)
23. Banci L, Benedetto M, Bertini I, Conte RD, Piccioli M, Viez-zoli MS. Solution structure of reduced monomeric Q133M2 Copper, Zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme? Biochemistry 1998; 37: 11780-11791. (Pubitemid 28400049)
24. Kato S, Saito M, Hirano A, Ohama E. Recent advances in research on neuropathological aspects of familial amyo-trophic lateral sclerosis with superoxide dismutase 1 gene mutations: Neuronal Lewy-body-like hyaline inclusions and astrocytic hyaline inclusions. Histol Histopathol 1999; 14: 973-989. (Pubitemid 29320361)
25. Nakashima K, Watanabe Y, Kuno N, Nanba E, Takahashi K. Abnormality of Cu/Zn superoxide dismutase (SOD1) activity in Japanese familial amyotrophic lateral sclerosis with two base pair deletion in the SOD1 gene. Neurology 45; 1995: 1019-1020.
26. Shibata N, Kobayashi M, Hirano A, et al. Morphological aspects of superoxide dismutase-1 mutation in amyo-trophic lateral sclerosis and its transgenic mouse model. Acta Histochem Cytochem 32; 1999: 17-30. (Pubitemid 29285244)
27. Rothstein JD, Bristol LA, Hosler B, Brown RH, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994; 91: 4155-4159. (Pubitemid 24143391)
28. Troy CM, Shelanski M. Down regulation of copper/zinc superoxide dismutase causes apoptotic death in PC 12 neuronal cells. Proc Natl Acad Sci USA 1994;91:63 84-6387.
29. Phillips JP, Tainer JA, Getzoff ED, Boulianne GL, Kirby K, Hilliker AJ. Subunit-destabilising mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium. Proc Natl Acad Sci USA 1995; 92: 8533-8534.
30. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dis-mutase mutation. Science 1994; 264: 1772-1775. (Pubitemid 24227760)
31. Andersen PM, Nilsson P, Ala-Hurula V, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genet 1995; 10: 61-65.
32. Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996; 13: 43-47. (Pubitemid 26139292)
33. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identiication of a novel insertion mutation. Ann Neurol 1997; 42: 803-807. (Pubitemid 27481554)
34. Shaw CE, Enayat ZE, Chioza BA, et al. Mutations in all ive exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390-394. (Pubitemid 28113604)
35. Brown RH Jr. SOD1 aggregates in ALS: Cause, correlate or consequence? Nature Med 1998; 12: 1362-1364.
36. Cookson MR, Shaw PJ. Oxidative stress and motor neuron disease. Brain Pathol 1999; 9: 165-186. (Pubitemid 29056526)
37. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993; 364: 584.
38. Brown RH Jr. Amyotrophic lateral sclerosis Recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692.
39. Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518. (Pubitemid 26044472)
40. Singh RJ, Karoui H, Gunther MR, Beckman JS, Mason RP, Kalyanaraman B. Re-examination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu,Zn superoxide dismutase mutants and H2O2. Proc Natl Acad Sci USA 1998; 95: 6675-6680.
41. Bruijn LI, Houseweart MK, Kato S, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281: 1851-1854. (Pubitemid 28450505)
42. Bruijn LI, Beal MF, Becher MW, et al. Elevated free nitroty-rosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 1997; 94: 7606-7611.
43. Ferrante RJ, Shinobu LA, Schulz JB, et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 1997; 42: 326-334. (Pubitemid 27391116)
44. Chou SM, Wang HS, Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohisto-chemical study. J Chem Neuroanat 1996; 10: 249-258. (Pubitemid 26196652)
45. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997; 42: 645-654.
46. Carri MT, Battistoni A, Polizio F, Desideri A, Rotilio G. Impaired copper binding by the H46R mutant of human Cu, Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett 1994; 356: 314-316.
47. Nishida CR, Gralla EB, Valentine JS. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci 1994; 91: 9906-9910. (Pubitemid 24311917)
48. Corson LB, Strain JJ, Culotta VC, Cleveland DW. Chaper-one-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc Natl Acad Sci USA 1998; 95: 6361-6366. (Pubitemid 28249017)
49. Shibata N, Hirano A, Kato S, et al. Advanced glycation end-products are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 1999; 97: 240-246. (Pubitemid 29137272)
50. Kato S, Horiuchi S, Nakashima K, et al. Astrocytic hyaline inclusions contain advanced glycation endoproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses. Acta Neuropathol 1999; 97: 260-266. (Pubitemid 29137275)
51. Kato S, Shimoda M, Morita T, et al. Neuropathology of famil-ial ALS with a mutation of the superoxide dismutase 1 gene. In: Nakano I, Hirano A, editors. Amyotrophic Lateral Sclerosis: Progress and perspectives in basic research and clinical application. Amsterdam: Elsevier Science, 1996; 117-122.
52. Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K, Ohama E. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: Multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 1996; 55: 1089-1101. (Pubitemid 26338021)
53. Kato S, Hayashi H, Nakashima K, et al. Pathological characterization of astrocytic hyaline inclusions in familial amyo-trophic lateral sclerosis. Am J Pathol 1997; 151: 611-620. (Pubitemid 27330081)
54. Shibata N, Hirano A, Kobayashi M, Asayama K. Superoxide dismutase-1 accumulation in Lewy body-like hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. In: Nakano I, Hirano A, editors. Amyotrophic Lateral Sclerosis: Progress and perspectives in basic research and clinical application. Amsterdam: Elsevier Science, 1996: 123-128.
55. Shibata N, Hirano A, Kobayashi M, et al. Immunohisto-chemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 1993; 26: 619-622.
56. Shibata N, Hirano A, Kobayashi M, et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-490. (Pubitemid 26112102)
57. Bruijn LI, Becher MW, Lee MK, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338. (Pubitemid 27111114)
58. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967; 16: 232-243.
59. Shibata N, Hirano A, Kobayashi M, et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994; 179: 149-152. (Pubitemid 24298580)
60. Pramatarova A, Goto J, Nanba E, et al. A two basepair deletion in the SOD1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 2061-2062. (Pubitemid 24341387)
61. Metcalf CW, Hirano A. Amyotrophic lateral sclerosis: Clini-copathological studies of a family. Arch Neurol 1971; 24: 518-523.
62. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145: 1271-1279. (Pubitemid 24378480)
63. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild-type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40.
64. Dal Canto MC, Gurney ME. A low expressor line of trans-genic mice carrying a mutant human Cu, Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol 1997; 93: 537-550. (Pubitemid 27239242)
65. Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-1116.
66. Brännström T, Nilsson KE, Marklund S. Transgenic mice with the D90A SOD1 mutation and motor neuron disease: a clinical, morphological, and biochemical study (abstract). Brain Pathol 1997; 7: 1073.
67. Shibata N, Hirano A, Kobayashi M, et al. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol 1998; 95: 136-142. (Pubitemid 28076007)
68. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151. (Pubitemid 24090096)
69. Monnier VM. Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM, editors. The Maillard Reaction in Aging, Diabetes, and Nutrition. New York: Alan Liss, 1989; 1-22.
70. Ahmed Mil, Thorpe SR, Baynes JW. Identification of Nε- carboxymethyllysine as a degradation product of fruc-toselysine in glycated protein. J Biol Chem 1986; 261: 4889-4894. (Pubitemid 17204276)
71. Nagai R, Ikeda K, Higashi T, et al. Hydroxyl radical mediates Nε-(carboxymethyl) lysine formation from Amadori product. Biochem Biophys Res Commun 1997; 234: 167-172. (Pubitemid 27267554)
72. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase: Identification of the in vitro glycated sites. J Biol Chem 1987; 262: 16969-16972. (Pubitemid 18017663)
73. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Site-speciic and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction: Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-18510.
74. Shinohara M, Thornalley PJ, Giardino I, et al. Overexpression of glyoxalase-1 in bovine enothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998; 101: 1142-1147. (Pubitemid 28125293)
75. Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycaemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996; 97: 1422-1428. (Pubitemid 26097031)
76. Fuh H, Yang D, Striker L, Striker G, Vlassara H. In vivo AGE-peptide injection induces kidney enlargement and glomerular hypertrophy in rabbits: Prevention by aminoguanidine. Diabetes 1992; 41: 9A.
77. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci iSA 1992; 89: 12043-12047. (Pubitemid 23004781)
78. Durham HD, Roy J, Dong L, Figlewicz DA. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model f ALS. J Neuropathol Exp Neurol 1997; 56: 523-530. (Pubitemid 27463093)
79. Kume S, Takeya M, Mori T, et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel speciic monoclonal antibody. Am J Pathol 1995; 147: 654-667.
80. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocam-pal neurons. Neurosci Lett 1996; 208: 53-56. (Pubitemid 26128106)
81. Tada J, Namikawa T, Wakayama I, Kihira T, Mizusawa H. An autopsy case of sporadic ALS with rapid clinical course and Lewy body-like intracytoplasmic inclusions in Onuf's nucleus. Neurol Med (Tokyo) 1994; 44: 377-384.
82. Kato T, Katagiri T, Hirano A, Sasaki H, Arai S. Sporadic lower motor neuron disease with Lewy body-like hyaline inclusions: a new subgroup? Acta Neuropathol 1988; 76: 208-211.
83. Matsumoto S, Kusaka H, Ito H, Shibata N, Asayama T, Imai T. Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions. Clin Neuropathol 1996; 15: 41-46. (Pubitemid 26022736)
84. Lowe J, Aldridge F, Lennox G, et al. Inclusions - bodies in motor cortex and brain-stem of patients with motor neuron disease are detected by immunocytochemical localization of ubiquitin. Neurosci Lett 1989; 105: 7-13. (Pubitemid 19248966)
85. Kihira T, Mizusawa H, Tada J, Namikawa T, Yoshida S, Yase Y. Lewy body-like inclusions in Onuf's nucleus from two cases of sporadic amyotrophic lateral sclerosis. J Neurol Sci 1993; 115: 51-57. (Pubitemid 23090185)
86. Kusaka H, Imai T, Hashimoto S, Yamamoto T, Maya K, Yamasaki M. Ultrastructural study of chromatolytic neurons in an adult-onset sporadic case of amyotrophic lateral sclerosis. Acta Neuropathol 1988; 75: 523-528. (Pubitemid 18075433)
87. Kusaka H, Matsumoto S, Imai T. Granulofilamentous profiles in lower motor neurons: a sporadic case of amyo-trophic lateral sclerosis with many Lewy body-like inclusions. Clin Neuropathol 1992; 11: 20-24.
88. Kusaka H, Hirano A. Cytopathology of motor neuron. In: David SY, editor. Motor Disorders. Philadelphia: Lippincott Williams & Wilkins, 1999: 93-101.
89. Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the Copper/Zinc superoxide dismutase gene. Ann Neurol 1998; 43: 703-710. (Pubitemid 28280213)
90. Takahashi H. Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene. Brain Nerve 1995; 47: 535-541.
91. Saida K, Ooi N, Nabeshima K, Asada Y, Kumamoto K, Mat-sukura S. An autopsy case of familial amyotrophic lateral sclerosis with an His(46)Arg substitution in exon 2 of Cu/Zn-superoxide dismutase gene (Japanese abstract). 39th Annual Meeting of the Societas Neurologica Japonica, Kyoto, 1998.
92. Shaw CE, Enayat ZE, Powell JF, et al. Familial amyotrophic lateral sclerosis: Molecular pathology of a patient with a SOD1 mutation. Neurology 1997; 49: 1612-1616. (Pubitemid 28015126)
93. Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 1996; 92: 395-403. (Pubitemid 26317107)
94. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neuroibrillary tangles. J Neurol Neurosurg Psychiatry 1995; 59: 266-270.
95. Rouleau GA, Clark AW, Rooke K, et al. SOD1 mutation is associated with accumulation of neuroilaments in amyo-trophic lateral sclerosis. Ann Neurol 1996; 39: 128-131. (Pubitemid 26052227)
96. Kokubo Y, Kuzuhara S, Narita Y, et al. An autopsy case of familial amyotrophic lateral sclerosis with argyrophilic inclusions associated with an Ile(113)Thr substitution in exon 4 of superoxide dismutase 1 gene. (Japanese abstract) Neuropathology 1998; 18(Suppl): 278.
97. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol 1998; 57: 895-904. (Pubitemid 28478000)
98. Takehisa Y, Ishizu H, Ujiie H, et al. Familial amyotrophic lateral sclerosis with novel mutation Leu126Ser in copper/zinc superoxide dismutase gene. Neuropathology 1999; 19(Suppl): 252.
99. Kadekawa J, Fujimura H, Ogawa Y, et al. A clinicopatholog-ical study of a patient with familial amyotrophic lateral sclerosis associated with a two base pair deletion in the copper/zinc superoxide dismutase (SOD1) gene. Acta Neuropathol 1997; 94: 617-622. (Pubitemid 27511185)
100. Murayama S, Namba E, Nishiyama K, et al. Molecular pathological studies of familial amyotrophic lateral sclerosis. Neuropathology 1997; 17(Suppl): 219.
101. Achkar CC, Bentel JM, Boylan JF, Scher HI, Gudas LJ, Miller WH Jr. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metabol Dis 1994; 22: 451-458. (Pubitemid 24158547)
102. Andersen PM, Nilsson P, Keranen ML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737. (Pubitemid 27443049)
103. Aoki M, Abe K, Houi K, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 1995; 37: 676-679.
104. Aoki M, Ogasawara M, Matsubara Y, et al. Mild ALS in Japan associated with novel SOD mutation. Nature Genet 1993; 5: 102-103.
105. Bereznai B, Winkler A, Borasio GD, Gasser T. A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscul Disord 1997; 7: 113-116. (Pubitemid 27168712)
106. de Belleroche J, Orrell RW, Marklund SL. Functional and structural correlates of 12 superoxide dismutase-1 mutations in UK families with amyotrophic lateral sclerosis (abstract). 6th International Symposium on ALS/MND, Dublin, 1995.
107. Elshafey A, Lanyon WG, Connor JM. Identification of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 363-364.
108. Enayat ZE, Orrell RW, Claus A, et al. Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1239-1240.
109. Esteban J, Rosen DR, Bowling AC, et al. Identiication of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyo-trophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-998. (Pubitemid 24189974)
110. Hirano M, Fujii J, Nagai Y, et al. A new variant Cu/Zn superoxide dismutase (Val7→Glu) deduced from lymphocytes mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-577. (Pubitemid 24343958)
111. Hosler BA, Nicholson GA, Sapp PC, et al. Three novel mutations and two variants in the gene for Cu/Zn superox-ide dismutase in familial amyotrophic lateral sclerosis. Neuromusc Disord 1996; 6: 361-366. (Pubitemid 26388003)
112. Ikeda M, Abe K, Ogasawara M, et al. A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 491-492.
113. Jones CT, Swingler RJ, Brock DJH. Identiication of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
114. Kawamata J, Hasegawa H, Shimohama S, Kimura J, Tanaka S, Ueda K. Leu106→Val (CTC→GTC) mutation of superoxide dismutase-1 gene in patient with familial amyotrophic lateral sclerosis in Japan (letter). Lancet 1994; 343: 1501. (Pubitemid 24176349)
115. Kawamata J, Shimohama S, Hasegawa H, Imura T, Kimura J, Ueda K. Deletion and point mutations in superoxide dismutase-1 gene in amyotrophic lateral sclerosis (abstract). XIth TMIN International Symposium, Tokyo, 1995.
116. Kawamata J, Shimohama S, Takano S, Harada K, Ueda K, Kimura J. Novel G16S (GGC→AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyo-trophic lateral sclerosis. Hum Mutat 1997; 9: 356-358. (Pubitemid 27157655)
117. Kostrzewa M, Burck-Lehmann U, M̈ller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene. Hum Mol Genet 1994; 3: 2261-2262.
118. Morita M, Aoki M, Abe K, et al. A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett 1996; 205: 79-82. (Pubitemid 26071319)
119. Moulard B, Camu W, Brice A. A previously undescribed mutation in the SOD1 gene in a French family with atypical ALS (abstract). 6th International Symposium on ALS/MND, Dublin, 1995.
120. Nakano R, Sato S, Inuzuka T, et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyo-trophic lateral sclerosis. Biochem Biophys Res Commun 1994; 200: 695-703. (Pubitemid 24146018)
121. Orrell RW, Habgood J, Rudge P, Lane RJ, de Belleroche JS. Dificulties in distinguishing sporadic from familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 810-812. (Pubitemid 26183820)
122. Orrell RW, Habgood J, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48: 746-751. (Pubitemid 27120118)
123. Pramatarova A, Figlewicz DA, Krizus A, et al. Identiications of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-596.
124. Rainero I, Pinessi L, Tsuda T, et al. SOD1 missense mutation in an Italian family with ALS. Neurology 1994; 44: 347-349. (Pubitemid 24070984)
125. Sapp PC, Rosen DR, Hosler BA, et al. Identiication of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord 1995; 5: 353-357.
126. Själander A, Beckman G, Deng H-X, Iqbal Z, Tainer JA, Sid-dique T. The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in northern Sweden and Finland. Hum Mol Genet 1995; 4: 1105-1108.
127. Watanabe M, Aoki M, Abe K, et al. A novel missense mutation (S134N) of the SOD1 gene in a patient with familial motor neuron disease (abstract). Xlth TMIN International Symposium, Tokyo, 1995.
128. Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EM. An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet 1995; 4: 1101-1104.
129. Bonner WM, Hatch CL, Wu RS. Ubiquitinated histones and chromatin. In: Rechsteiner M, editor. Ubiquitin. New York: Plenum, 1988: 157-172.
130. Asayama K, Burr IM. Joint puriication of mangano and cuprozinc superoxide dismutases from a single source: A simpliied method. Anal Biochem 1984; 136: 336-339.